No abstract

This study characterized the expression of melatonin receptor type 1 (MT 1 ) protein in sheep ovaries, evaluated melatonin effects on primordial follicle survival and development after in vitro culture of ovarian tissue and verified the possible involvement of the phosphatidylinositol-3-kinase/protein kinase B/forkhead box O3a (PI3K/Akt/FOXO3a) pathway in the melatonin actions. Ovine ovarian fragments were cultured in α-modified minimum essential medium alone (α-MEM + ) or supplemented with 100, 500, or 1000 pg/ml melatonin for 7 days. PI3K inhibition was performed through pretreatment of ovarian fragments with LY294002. Thereafter, immunohistochemistry was performed to evaluate the expression of cleaved caspase-3, Akt, phosphorylated-Akt, and phosphorylated-FOXO3a (p-FOXO3a). The immunohistochemical localization of the MT 1 receptor protein was documented in sheep preantral and antral follicles. After in vitro culture, 100 pg/ml melatonin showed higher follicular survival and activation than α-MEM + and other melatonin concentrations.After PI3K inhibition, there was an increase in cleaved caspase-3-positive follicles, and a decrease in the primordial follicle activation, Akt phosphorylation, and nuclear exclusion of p-FOXO3a. In conclusion, MT 1 receptor protein is present in the sheep ovary.Furthermore, 100 pg/ml melatonin maintains survival and stimulates activation of primordial follicles through the PI3K/Akt/FOXO3a signaling pathway after in vitro culture of sheep ovarian tissue. K E Y W O R D S hormone receptor, immunohistochemistry, in vitro culture, ovarian cortex, preantral follicle 1 | INTRODUCTION In vitro activation of primordial follicles cultured within the ovary itself is an essential tool to study the early follicle development and optimize the use of the female germ cell pool (Telfer & Zelinski, 2013; J. J. Wang et al., 2017). Studies on in vitro activation of primordial follicles, and subsequent growth and maturation have gained a lot of attention as a potential source of mature eggs for in vitro fertilization and embryo transfer, followed by the delivery of healthy born

No abstract

This study aimed to evaluate the productive performance, carcass yield, and intestinal morphometry of broiler chickens subjected to diets with the inclusion of buriti oil. Buriti oil is an energy food that can be used in chicken feed to replace soybean oil, which has a high cost in production, also has its anti-inflammatory, antioxidant, and antimicrobial properties, which can provide benefits in chicken feed. 180 male broilers of the Ross lineage were used, distributed in a completely randomized design with 3 treatments and 6 replicates of 10 birds per experimental unit. The experimental phase took place from 14 to 28 days and levels 0; 0.75 and 1.50% of buriti oil were added to the corn and soybean-based feed. It can be inferred that the buriti oil-based diets in the diet with insertion of levels of 0%, 0.75% and 1.50% did not differ significantly for the productive performance variables, but in relation to the productive yield there was a significant difference for carcass yield accompanied by greater disposition of abdominal fat, thigh and heart fat, a common effect in the use of oils. Although no statistical differences were observed for most of the variables in the assessment of intestinal morphometry, there was an increase in the crypt depth of the duodenum and ileum and an increase in the muscle layer of the duodenum and jejunum, which may have been caused by some injury to the intestine and not by direct effect of buriti oil. In the other variables there was no difference between treatments and it is concluded that buriti oil did not harm the performance, yield and intestinal morphometry of broiler chickens from 14 to 28 days of age.